Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Pending
Company Name
ADGERO BIOPHARMACEUTICALS HOLDINGS, INC
Proposed Ticker
N/A
CUSIP
N/A
Business Description
A biopharmaceutical company, focused on the development of photodynamic therapy (“PDT”) for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications.
Lead Underwriter
N/A
Co-Managers
N/A
Initial Shares
3,467,680
Revised Initial Shares
N/A
Initial Price
$5.00-$5.00
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
